BR100 Increased By (1.3%)
BR30 Increased By (1.71%)
KSE100 Increased By (1.16%)
KSE30 Increased By (1.18%)
AGHA 6.08 Increased By ▲ 0.05 (0.83%)
BECO 4.17 Increased By ▲ 0.31 (8.03%)
BML 60.55 Decreased By ▼ -0.45 (-0.74%)
BOP 28.87 Increased By ▲ 0.78 (2.78%)
CNERGY 11.97 Increased By ▲ 0.23 (1.96%)
CSIL 5.55 Increased By ▲ 0.25 (4.72%)
FCCL 56.05 Increased By ▲ 1.59 (2.92%)
FFL 13.01 Decreased By ▼ -0.06 (-0.46%)
FNEL 1.15 Increased By ▲ 0.04 (3.6%)
KEL 5.81 Increased By ▲ 0.18 (3.2%)
KOSM 5.38 Increased By ▲ 0.04 (0.75%)
LOTCHEM 24.00 Increased By ▲ 0.17 (0.71%)
MLCF 95.25 Increased By ▲ 2.27 (2.44%)
NBP 166.21 Increased By ▲ 3.01 (1.84%)
NCPL 48.50 Increased By ▲ 0.23 (0.48%)
NPL 50.36 Increased By ▲ 0.65 (1.31%)
OGDC 307.50 Increased By ▲ 3.87 (1.27%)
PACE 9.14 Increased By ▲ 0.17 (1.9%)
PAEL 32.20 Increased By ▲ 0.29 (0.91%)
PIBTL 13.10 Increased By ▲ 0.36 (2.83%)
PPL 215.65 Increased By ▲ 2.74 (1.29%)
PRL 85.83 Increased By ▲ 1.49 (1.77%)
PTC 45.75 Increased By ▲ 0.76 (1.69%)
SSGC 23.10 Increased By ▲ 0.27 (1.18%)
TBL 9.05 Increased By ▲ 0.17 (1.91%)
TELE 6.62 Increased By ▲ 0.12 (1.85%)
TPL 25.37 Increased By ▲ 1.11 (4.58%)
TPLP 12.96 Increased By ▲ 0.97 (8.09%)
TREET 23.25 Increased By ▲ 0.11 (0.48%)
TRG 52.39 Increased By ▲ 0.92 (1.79%)
World

Philippines to evaluate China's Sinopharm COVID-19 vaccine for emergency use

  • Sinopharm is the sixth vaccine maker to apply for emergency use authorisation in the Southeast Asian country.
Published Updated
By

MANILA: China's Sinopharm has applied for emergency use of its COVID-19 vaccine in the Philippines, the chief of Manila's Food and Drug Administration (FDA) said on Tuesday.

Sinopharm is the sixth vaccine maker to apply for emergency use authorisation in the Southeast Asian country.

The Philippines, which has the second-highest number of COVID-19 cases and deaths in Southeast Asia, has approved the vaccines of Pfizer, AstraZeneca and Sinovac for emergency use.

Comments

Comments are closed for this article.